Yes position
Will Viking Therapeutics be acquired before 2027?
Ends Dec 31, 2026- Implied probability
- 36%
- Current value
- $118.12
- Potential payout
- $328.12
- Potential profit
- $210
- Multiplier
- 2.78x
- User PnL
- $18.13
Polymarket Trader
serendipity-flags
0xfce071daecef32f4d095b358a2c2c9da8299c8da
Public profile Partial data Delayed section
- Open value
- $246.39
- Realized PnL
- $0
- Win rate
- Unavailable
- Open positions
- 2
- Closed positions
- 0
- Markets traded
- Unavailable
Current Predictions
Open positions
No position
FDA approves Retatrutide this year?
Ends Dec 31, 2026- Implied probability
- 88.5%
- Current value
- $128.26
- Potential payout
- $144.93
- Potential profit
- $16.67
- Multiplier
- 1.13x
- User PnL
- $28.26
Resolved Context
Closed positions
No closed positions returned for this trader.
Trades
Recent trades
Latest visible trades for this Polymarket trader.
- Will Viking Therapeutics be acquired before 2027?Yes 32% 78.13 shares
- Will Viking Therapeutics be acquired before 2027?Yes 30% 83.33 shares
- Will Viking Therapeutics be acquired before 2027?Yes 30% 166.67 shares
- FDA approves Retatrutide this year?No 69% 144.93 shares